Takeda Pharmaceutical Co Ltd (TKPHF) stock
TKPHFOTCPharmaceutical PreparationsAlso trades as TAK
$39.00+0.36 (+0.93%)
Close on Oct 19, 2026Market cap $134.41BP/E –Yield –
Takeda Pharmaceutical ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2026 it was ¥727.34B, down 34.1% from the year before. The highest annual figure on record is ¥1.15T in fiscal 2023.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | ¥727.34B | -34.1% |
| FY2025 | Mar 31, 2025 | ¥1.10T | +17.2% |
| FY2024 | Mar 31, 2024 | ¥942.08B | -18.4% |
| FY2023 | Mar 31, 2023 | ¥1.15T | +10.6% |
| FY2022 | Mar 31, 2022 | ¥1.04T | -2.3% |
| FY2021 | Mar 31, 2021 | ¥1.07T | +56.3% |
| FY2020 | Mar 31, 2020 | ¥684.06B | +40.9% |
| FY2019 | Mar 31, 2019 | ¥485.38B | +14.5% |
| FY2018 | Mar 31, 2018 | ¥423.92B | +29.5% |
| FY2017 | Mar 31, 2017 | ¥327.29B | – |